Funding provided by Nice & Green SA, a Swiss private investor, of €8 million in two tranches of €4 million each, plus optional additional tranches of up to €5 million each to be executed in the ...
Read moreScientists have managed to expand their precision medicine platform, allowing a detailed study of tumors of the nervous system.
Read moreLa información epigenética obtenida de muestras de sangre de pacientes con cáncer avanzado puede informar sobre la evolución de la enfermedad y ayudar a seleccionar el tratamiento adecuado.
Read moreThe Association has awarded Oryzon a 498,690 USD grant through its Lawrence and Isabel Barnett Drug Development Program to support the regulatory preclinical development of ORY-4001, a highly selectiv...
Read moreThe ibs.GRANADA is pleased to announce the approval of an ambitious European project funded with more than 600,000 euros by the European Union to improve the health of children and reduce the economic...
Read moreUn atlas financiado por los Institutos Nacionales de Salud de EE. UU. caracteriza más de 32 millones de células del cerebro de ratón.
Read moreOryzon Genomics S.A. se complace en compartir que, de acuerdo al ranking publicado por la Unión Europea, se encuentra entre las 1000 empresas europeas con mayor inversión en I+D, en concreto en la p...
Read moreCientíficos del St. Jude Children’s Research Hospital identifican los mecanismos genéticos y epigenéticos que determinan la predisposición a padecer este cáncer de riñón infantil, lo que repe...
Read moreOryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that its management will give ...
Read moreUn grupo de investigación del Instituto de Biología Integrativa de Sistemas (i2SysBio), centro mixto del Consejo Superior de Investigaciones Científicas (CSIC) y la Universitat de València (UV), h...
Read moreOryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with a strong unmet medical need, today announced topline results from the Pha...
Read moreThe study provides crucial insights into cancer evolution, identifying the genes most affected by changes in mutation risk and shedding light on the dynamic relationship between cell proliferation, mu...
Read more